Pharmacology and Infectious Diseases

\r\n Pandemic, epidemic and endemic infectious diseases are united by a common problem to identify potential pharmacological interventions to treat infections. The large numbers of emerging and neglected infectious diseases are badly affecting the poorest members of the global society; new ways are required to develop high productivity discovery systems that can be applied to a large number of pathogens. The basis for developing methods to prioritize a priori potential drug targets analyzes the pharmacological landscape of an infectious disease.

\r\n
    \r\n
  • \r\n

    \r\n Inflammatory drug development

    \r\n
  • \r\n
  • \r\n

    \r\n NSAIDS drug development

    \r\n
  • \r\n
  • \r\n

    \r\n Anti-inflammatory drugs and NSAIDS

    \r\n
  • \r\n
\r\n

    Related Conference of Pharmacology and Infectious Diseases

    Pharmacology and Infectious Diseases Conference Speakers